Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
•
Primary Care
Is it safe to prescribe Invokana or Metformin for patients taking Biktarvy?
Related Questions
Do you routinely monitor INR when starting GLP1 R agonist therapy on patients taking warfarin?
What is the typical timeline for remission of autoimmune hypoglycemia?
Outside of teplizumab, what therapies do you recommend for preserving beta cell function in patients with early stage type 1 diabetes mellitus?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
After what time frame off GLP-1 RA therapy should you restart at the lowest starting dose?
What is the recommended frequency and duration of exercise bouts in order to sustain the beneficial effects of exercise on insulin sensitivity?
Is GLP-1 therapy a viable treatment option for a patient with Type 2 Diabetes complicated by atherosclerotic heart disease and cholelithiasis?
Do you recommend the use of GLP1 R agonist therapy in patients with T1DM for weight loss?
